Enoxaparin-sodiumMajor bleeding, lack of efficacy and off-label use: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1962卷 / 1期

关键词：

D O I：

10.1007/s40278-023-41849-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：179 / 179

相关论文

共 50 条

[1] Enoxaparin-sodiumMajor bleeding and minor bleeding: 2 case reports
[J]. Reactions Weekly, 2023, 1957 (1) : 235 - 235
[2] Antiplatelets/enoxaparin-sodiumMajor bleeding: case report
[J]. Reactions Weekly, 2020, 1829 (1) : 74 - 74
[3] Multiple drugsMenstrual bleeding, lack of efficacy and off-label use: 2 case reports
[J]. Reactions Weekly, 2024, 2021 (1) : 389 - 389
[4] PaliperidoneWeight gain, off-label use and lack of efficacy: 2 case reports
[J]. Reactions Weekly, 2020, 1824 (1) : 231 - 231
[5] Multiple drugsBleeding, off-label use and lack of efficacy: 2 case reports
[J]. Reactions Weekly, 2021, 1859 (1) : 237 - 238
[6] Phenylephrine/tamsulosinPriapism, lack of efficacy and off-label use: 2 case reports
[J]. Reactions Weekly, 2020, 1828 (1) : 424 - 424
[7] Multiple drugsDissociation, off-label use and lack of efficacy: 2 case reports
[J]. Reactions Weekly, 2023, 1949 (1) : 303 - 303
[8] Multiple drugsFever, off-label use and lack of efficacy: 2 case reports
[J]. Reactions Weekly, 2020, 1833 (1) : 271 - 271
[9] FavipiravirHyperuricaemia and lack of efficacy following off-label use: 2 case reports
[J]. Reactions Weekly, 2022, 1903 (1) : 182 - 182
[10] AntineoplasticsVarious toxicities, lack of efficacy and off-label use: 2 case reports
[J]. Reactions Weekly, 2023, 1959 (1) : 91 - 91

← 1 2 3 4 5 →